ACCESSION: MSBNK-SMB_Measured-HSA015P0083008
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL01_pos_1449': {'bp': 1448066.0, 'sum': 2225140.0}, 'EL03_pos_1510': {'bp': 819460.0, 'sum': 1767220.0}, 'EL09_pos_1450': {'bp': 1031010.0, 'sum': 1719442.0}, 'EL16_pos_1445': {'bp': 882442.0, 'sum': 1534455.0}, 'EL12_pos_1443': {'bp': 901461.0, 'sum': 1568285.0}, 'EL21_pos_1449': {'bp': 930546.0, 'sum': 1603995.0}, 'EL17_pos_1445': {'bp': 1056997.0, 'sum': 1747359.0}, 'EL02_pos_1450': {'bp': 973716.0, 'sum': 1671903.0}, 'EL05_pos_1445': {'bp': 672616.0, 'sum': 1337654.0}, 'EL22_pos_1456': {'bp': 1054005.0, 'sum': 1749154.0}, 'EL19_pos_1455': {'bp': 784316.0, 'sum': 1435327.0}, 'EL23_pos_1449': {'bp': 1193090.0, 'sum': 1876621.0}, 'EL06_pos_1449': {'bp': 1071651.0, 'sum': 1769179.0}, 'EL20_pos_1445': {'bp': 851999.0, 'sum': 1518618.0}, 'EL15_pos_1450': {'bp': 1055949.0, 'sum': 1697280.0}, 'EL24_pos_1455': {'bp': 914113.0, 'sum': 1564395.0}, 'EL11_pos_1449': {'bp': 849710.0, 'sum': 1513867.0}, 'EL04_pos_1456': {'bp': 1362679.0, 'sum': 2074994.0}, 'EL08_pos_1449': {'bp': 1089839.0, 'sum': 1765365.0}, 'EL14_pos_1455': {'bp': 1065382.0, 'sum': 1752632.0}, 'EL07_pos_1450': {'bp': 1023437.0, 'sum': 1690140.0}, 'EL18_pos_1451': {'bp': 935542.0, 'sum': 1594636.0}, 'EL13_pos_1450': {'bp': 1334317.0, 'sum': 2049153.0}, 'EL10_pos_1445': {'bp': 937756.0, 'sum': 1590684.0}}
COMMENT: RETENTION_TIME_STDEV 0.008
COMMENT: PRECURSOR_M/Z_RAW 83.061077
COMMENT: PRECURSOR_M/Z_STDEV 0.000030
COMMENT: PRECURSOR_IN_MS1 mz 83.060380; int 107.301; delta(ppm) 0.270555
COMMENT: PROPOSED_CHARGE_STATE +1; mz 84.063739; int 5.022; cor 0.734
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.073; C4H6N2; [M+H]+; delta(ppm) 0.073123
COMMENT: PROPOSED_MF MS-FINDER 3.462; C4H6N2; [M+H]+; delta(ppm) 0.064554
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.061; C4H6N2; [M+H]+; delta(ppm) 0.064554
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H6N2; [M+H]+; delta(ppm) 0.064554
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; XKVUYEYANWFIJX-UHFFFAOYSA-N; C4H6N2; MassbankEU:SM804001 3-Methylpyrazole5-methyl-1H-pyrazole3-Methyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; LXBGSDVWAMZHDD-UHFFFAOYSA-N; C4H6N2; MassbankEU:SM801701 2-Methylimidazole2-METHYLIMIDAZOLE2-methyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.867; LXBGSDVWAMZHDD-UHFFFAOYSA-N; [M+H]+; CC1=NC=CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.850; WCFAPJDPAPDDAQ-UHFFFAOYSA-N; [M+H]+; C1NC=CC=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.733; MCTWTZJPVLRJOU-UHFFFAOYSA-N; [M+H]+; CN1C=CN=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.705; XLSZMDLNRCVEIJ-UHFFFAOYSA-N; [M+H]+; CC1=CNC=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.467; RIKMMFOAQPJVMX-UHFFFAOYSA-N; [M+H]+; CC1=CNN=C1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.809; XLSZMDLNRCVEIJ-UHFFFAOYSA-N; [M+H]+; 4-methylimidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.755; MCTWTZJPVLRJOU-UHFFFAOYSA-N; [M+H]+; 1-methyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.609; RIKMMFOAQPJVMX-UHFFFAOYSA-N; [M+H]+; Fomepizole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.608; LXBGSDVWAMZHDD-UHFFFAOYSA-N; [M+H]+; 2-methylimidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.447; WCFAPJDPAPDDAQ-UHFFFAOYSA-N; [M+H]+; 1,2-dihydropyrimidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.247; UQFQONCQIQEYPJ-UHFFFAOYSA-N; [M+H]+; N-methylpyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.233; WRLAXLNSBDVNRL-UHFFFAOYSA-N; [M+H]+; 2,5-dihydropyrimidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.210; XKVUYEYANWFIJX-UHFFFAOYSA-N; [M+H]+; 3-methylpyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.133; BKWQKVJYXODDAC-UHFFFAOYSA-N; [M+H]+; 1,2-dihydropyridazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.647; YNZAFFFENDLJQG-UHFFFAOYSA-N; [M+H]+; UNPD133976
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.595; QLSWIGRIBOSFMV-UHFFFAOYSA-N; [M+H]+; 1H-pyrrol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WCFAPJDPAPDDAQ-UHFFFAOYSA-N; [M+H]+; 1,2-dihydropyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WRLAXLNSBDVNRL-UHFFFAOYSA-N; [M+H]+; 2,5-dihydropyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.871; BKWQKVJYXODDAC-UHFFFAOYSA-N; [M+H]+; 1,2-dihydropyridazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.811; RIKMMFOAQPJVMX-UHFFFAOYSA-N; [M+H]+; Fomepizole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.811; UQFQONCQIQEYPJ-UHFFFAOYSA-N; [M+H]+; N-methylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.776; XKVUYEYANWFIJX-UHFFFAOYSA-N; [M+H]+; 3-methylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.744; MCTWTZJPVLRJOU-UHFFFAOYSA-N; [M+H]+; 1-methyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.744; XLSZMDLNRCVEIJ-UHFFFAOYSA-N; [M+H]+; 4-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.744; LXBGSDVWAMZHDD-UHFFFAOYSA-N; [M+H]+; 2-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.717; QLSWIGRIBOSFMV-UHFFFAOYSA-N; [M+H]+; 1H-pyrrol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.659; YNZAFFFENDLJQG-UHFFFAOYSA-N; [M+H]+; UNPD133976
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.856; LXBGSDVWAMZHDD-UHFFFAOYSA-N; [M+H]+; 2-methyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.672; RIKMMFOAQPJVMX-UHFFFAOYSA-N; [M+H]+; 4-methyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.424; MCTWTZJPVLRJOU-UHFFFAOYSA-N; [M+H]+; 1-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.930; XLSZMDLNRCVEIJ-UHFFFAOYSA-N; [M+H]+; 5-methyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.452; DELJOESCKJGFML-UHFFFAOYSA-N; [M+H]+; 3-aminobut-2-enenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.155; UIVATUPCWVUVIM-UHFFFAOYSA-N; [M+H]+; 1-aminocyclopropane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.154; PBIUUJCEMUAWJJ-UHFFFAOYSA-N; [M+H]+; azetidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.152; CSIFGMFVGDBOQC-UHFFFAOYSA-N; [M+H]+; 3-iminobutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; BYEOBIZRFGJPGG-OWOJBTEDSA-N; [M+H]+; (E)-4-aminobut-2-enenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.049; XKVUYEYANWFIJX-UHFFFAOYSA-N; [M+H]+; 5-methyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; UQFQONCQIQEYPJ-UHFFFAOYSA-N; [M+H]+; 1-methylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.660; YNZAFFFENDLJQG-UHFFFAOYSA-N; [M+H]+; pyrrol-1-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H7N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.334
MS$FOCUSED_ION: PRECURSOR_M/Z 83.060380
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-9000000000-0a9169a6f98762177f68
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0024888 3.5406 53.003186 1.1509 1.13 -0.1957 23 ?
  53.0388979 18.8122 53.039596 0.7353 5.88 -0.4870 24 f{C4H5}/6.06ppm,p-H2N2
  55.0180894 4.9645 55.018797 0.9088 1.84 -0.1028 23 ?
  55.0545172 77.9273 55.055225 0.3269 24.30 -0.3826 24 f{C4H7}/5.28ppm,p-N2
  56.0497465 108.2857 56.050459 0.2676 12.02 0.6922 24 f{C3H6N1}/4.83ppm,p-C1H1N1
  56.9650348 12.3052 56.965751 0.7373 3.07 -0.4974 24 ?
  64.9788749 27.7828 64.979614 0.3694 5.96 0.4174 24 ?
  65.0387164 3.2945 65.039455 1.1224 1.12 -0.1729 17 ?
  71.9519807 6.0062 71.952724 1.0007 1.55 -0.2931 22 ?
  79.0542899 38.2060 79.055022 0.3542 11.85 -0.3183 24 ?
  80.0576096 4.6943 80.058339 1.0118 1.62 -0.4634 23 ?
  81.0335343 5.8851 81.034261 1.0119 2.28 -0.4078 24 ?
  81.0448131 3.8043 81.045540 1.2832 1.55 0.1047 23 f{C4H5N2}/1.09ppm,p-H2
  81.0528544 3.8801 81.053581 1.2338 1.21 -0.2035 24 ?
  81.0699278 41.7779 81.070654 0.2960 14.37 -0.3948 24 ?
  82.0651853 3.7059 82.065908 1.1211 1.45 -0.2158 19 ?
  82.0732533 5.0167 82.073976 0.8163 2.01 -0.0683 22 ?
  82.9893091 48.8736 82.990029 0.4338 9.19 0.2713 24 ?
  83.0495893 99.0775 83.050309 1.4690 29.70 -0.1569 17 ?
  83.0604409 999.0000 83.061160 0.2889 0.00 1.0000 24 f{C4H7N2}/0.80ppm,p
  84.0444294 92.4125 84.045145 0.3332 34.30 0.2235 24 ?
  84.0636699 39.2946 84.064385 0.8565 2.90 0.8443 24 ?
  84.0807624 9.1045 84.081478 1.0228 2.70 -0.1070 24 ?
  84.9597036 15.3543 84.960415 0.8828 3.69 -0.1496 24 ?
  85.0284131 6.1121 85.029125 1.1173 2.65 -0.1217 24 ?
PK$NUM_PEAK: 25
PK$PEAK: m/z int. rel.int.
  53.002489 3.54 3
  53.038898 18.81 18
  55.018089 4.96 4
  55.054517 77.93 77
  56.049746 108.29 108
  56.965035 12.31 12
  64.978875 27.78 27
  65.038716 3.29 3
  71.951981 6.01 6
  79.054290 38.21 38
  80.057610 4.69 4
  81.033534 5.89 5
  81.044813 3.80 3
  81.052854 3.88 3
  81.069928 41.78 41
  82.065185 3.71 3
  82.073253 5.02 5
  82.989309 48.87 48
  83.049589 99.08 99
  83.060441 999.00 999
  84.044429 92.41 92
  84.063670 39.29 39
  84.080762 9.10 9
  84.959704 15.35 15
  85.028413 6.11 6
//
